HealthLynked Corp. (OTCQB: HLYK), a healthcare technology company focused on AI-powered patient engagement, care coordination and provider connectivity, has selected DRCARE247 as its telemedicine partner. The partnership will integrate virtual care into the HealthLynked mobile application and website, allowing users to move from AI-powered health guidance to provider discovery, appointment scheduling, virtual consultations and medical record management within a single platform.
The integration is expected to begin launching in selected geographic regions over the next three months, followed by expansion into additional U.S. markets, subject to provider availability and applicable state requirements. The telemedicine platform will work alongside the company’s AI-powered patient assistant and, where clinically appropriate and permitted, may include prescription management as part of virtual consultations.
This move matters because it signals a further consolidation of digital health tools into unified platforms, potentially reducing fragmentation for patients who currently navigate multiple apps and portals. By adding telemedicine, HealthLynked aims to create a more seamless care journey from symptom assessment to treatment, which could improve outcomes and lower costs. For providers, the integration may offer a scalable way to extend their reach and manage patient flow more efficiently.
HealthLynked’s cloud-based platform already connects patients with providers for virtual or in-office appointments and consolidates medical records into one secure, accessible location. With AI-driven insights, integrated telehealth services, and intelligent patient engagement tools, the company empowers patients and providers to coordinate care more effectively while delivering savings on prescriptions and healthcare services. The platform supports enterprise partnerships, offering scalable solutions to healthcare networks, employers, insurers, accountable care organizations, and digital health innovators.
The partnership with DRCARE247 is a strategic step for HealthLynked as it seeks to differentiate itself in a crowded telehealth market. By embedding virtual care directly into its existing ecosystem, the company may increase user engagement and retention, while also creating new revenue opportunities through virtual consultations and prescription management. Investors and industry observers will be watching to see how quickly the rollout progresses and whether it drives adoption among both patients and enterprise partners.
For more details on the partnership, the full press release is available at https://ibn.fm/HVq1Y. HealthLynked’s latest news and updates can be found in its newsroom at https://ibn.fm/HLYLK. The announcement was distributed through BioMedWire, a specialized communications platform focused on the biotechnology, biomedical sciences and life sciences sectors. BioMedWire is part of the Dynamic Brand Portfolio at IBN, which delivers wire solutions through InvestorWire and offers services such as editorial syndication to 5,000+ outlets and social media distribution. The company also provides corporate communications solutions tailored to private and public companies.
